News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Revolutionary new HIV drug approved by Pharmac

August 24, 2006

Revolutionary new HIV drug approved by Pharmac

A revolutionary new treatment against HIV will be funded for New Zealanders from September 1st by Pharmac, and the New Zealand AIDS Foundation is welcoming the decision.

Fuzeon (AKA enfuvirtide or T20) is a new type of drug called an entry inhibitor, which blocks the HIV virus outside the body’s cells, rather than attempting to treat it once it is already inside. It will be of most benefit to HIV-positive people who are failing their current treatment regimes.

“A significant number of the 1700 people living with HIV in New Zealand today are receiving antiretroviral medications, and will need access to new treatments as their virus develops resistance,” says NZAF Positive Health Manager Eamonn Smythe. “The ability to have alternative medications available is one that can mean the difference between life and death for some.”

NZAF is also pleased that the approval process for Fuzeon through Pharmac has taken only half the time of the last anti-HIV drug, Kaletra, which took almost three years to become fully available.

“This hopefully bodes well for two other medications awaiting funding, Reyataz and Tenofovir, which have been available in Australia for two and four years respectively,” Smythe says. “Both these medications are needed by people living today here in New Zealand, and are widely used elsewhere in the world.”

ENDS

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Legendary Bassist David Friesen Plays Wellington’s Newest Jazz Venue

Friesen is touring New Zealand to promote his latest album Another Time, Another Place, recorded live at Auckland's Creative Jazz Club in 2015. More>>

Howard Davis Review: The Father - Descending Into The Depths of Dementia

Florian Zeller's dazzling drama The Father explores the effects of a deeply unsettling illness that affects 62,000 Kiwis, a number expected to grow to 102,000 by 2030. More>>


Howard Davis Review: Blade Runner Redivivus

When Ridley Scott's innovative, neo-noir, sci-fi flick Blade Runner was originally released in 1982, at a cost of over $45 million, it was a commercial bomb. More>>

14-21 October: New Zealand Improv Festival In Wellington

Imagined curses, Shibuya’s traffic, the apocalypse, and motherhood have little in common, but all these and more serve as inspiration for the eclectic improvised offerings coming to BATS Theatre this October for the annual New Zealand Improv Festival. More>>

ALSO:

Bird Of The Year Off To A Flying Start

The competition asks New Zealanders to vote for their favourite bird in the hopes of raising awareness of the threats they face. More>>

Scoop Review Of Books:
K Emma Ng's Old Asian, New Asian

This book, written by a young second-generation Chinese New Zealander, gives many examples of the racism that Asian New Zealanders experience. More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION